Novo Nordisk (NYSE: NVO) presented at Deutsche Banks European Champions Conference, with the broker holding its buy rating and DKK290 target price on the Danish pharmaceutical company
Theres almost no human trials
In the multicenter PIVENS ( PI oglitazone versus V itamin E versus placebo for the treatment of N onalcoholic S teatohepatitis) trial, 247 subjects with MASH but not diabetes mellitus were randomized to receive 30 mg/day of pioglitazone (an insulin-sensitizing drug), 800 IU/day (536 mg/day) of RRR --tocopherol, or a placebo for 96 weeks (97)
Toxin reduction Reduce nephrotoxic exposures, unnecessary NSAIDs, smoking, heavy metals, pesticides, contaminated water and highly processed phosphate additives
We know, youve heard it before and tried hydroquinone
Genetic testing is used to see if a person has the genetic variants that cause dEDS